CNSX:LOVE

Cannara Biotech Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume69,070 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive LOVE News and Ratings via Email

Sign-up to receive the latest news and ratings for Cannara Biotech and its competitors with MarketBeat's FREE daily newsletter.

About Cannara Biotech

Cannara Biotech Inc. is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility. Leveraging Quebec's low electricity costs, Cannara will produce high-grade indoor cannabis, specializing in derivative products and brands.

The Lovesac Company (NASDAQ:LOVE) Shares Could Be 45% Below Their Intrinsic Value Estimate
October 22, 2021 | finance.yahoo.com

Lovesac Debuts Immersive Surround Sound by Harman Kardon With the Launch of Sactionals StealthTech Sound + Charge
October 18, 2021 | finance.yahoo.com

Cannara Biotech's (CVE:LOVE) investors will be pleased with their notable 67% return over the last year
October 11, 2021 | finance.yahoo.com

The Lovesac Company Announces Product Demonstration Event
October 4, 2021 | finance.yahoo.com

Cannara's Valleyfield Facility Receives Processing and Cultivation License
September 27, 2021 | finance.yahoo.com

Notable Lovesac Insider Makes $1.10 Million Sale
September 15, 2021 | finance.yahoo.com

Lovesac soars on Q2 earnings beat
September 10, 2021 | finance.yahoo.com

Investors Should Look at These 2 Big Thursday Winners
September 9, 2021 | finance.yahoo.com

Lovesac earnings beat expectations with help from a Costco pop-up shop
September 9, 2021 | finance.yahoo.com

RH Earnings Soar Past Expectations Despite Covid Cases Surging Again
September 8, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: CNSX
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: CNSX:LOVE
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: cannara.ca
Phone: N/A
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

1.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cannara Biotech.

5.0 Community Rank

Outperform Votes
Cannara Biotech has received 48 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cannara Biotech has received 11 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cannara Biotech has received 81.36% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cannara Biotech and other stocks. Vote “Outperform” if you believe LOVE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LOVE will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cannara Biotech does not currently pay a dividend.
Dividend Growth
Cannara Biotech does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cannara Biotech insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Cannara Biotech (CNSX:LOVE) Frequently Asked Questions

What stocks does MarketBeat like better than Cannara Biotech?: Wall Street analysts have given Cannara Biotech a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cannara Biotech wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
Who are some of Cannara Biotech's key competitors?: Some companies that are related to Cannara Biotech include Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), CannPal Animal Therapeutics (CP1), Cansortium (CNTMF), Chalice Brands (GLDFF), Charlotte's Web (CWBHF) and China Auto Logistics (CALI).
View all of LOVE's competitors.
What other stocks do shareholders of Cannara Biotech own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cannara Biotech investors own include Aurora Cannabis (ACB), FSD Pharma (HUGE), Aurora Cannabis (ACB), (APHA), Brookfield Property Partners (BPY), Cross Timbers Royalty Trust (CRT), Emerald Health Therapeutics (EMH), HEXO (HEXO), Harvest One Cannabis (HVT) and KushCo (KSHB).
What is Cannara Biotech's stock symbol?: Cannara Biotech trades on the CNSX under the ticker symbol "LOVE."
How do I buy shares of Cannara Biotech?: Shares of LOVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Cannara Biotech's official website?: The official website for Cannara Biotech is cannara.ca.

This page was last updated on 10/25/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.